---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-026792"
form_type: "8-K"
ticker: "AMS"
cik: "0000744825"
company_name: "AMERICAN SHARED HOSPITAL SERVICES"
filed_at: "2022-11-10T23:59:59+00:00"
generated_at: "2026-06-22T00:18:44.957988+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# American Shared Hospital Services Q3 revenue up 18% to $4.8M; net income $0.05 per share vs $0.01

## Summary
- Revenue $4.828M (+17.8% YoY); net income $316K ($0.05 diluted EPS) vs $33K ($0.01) prior year.
- Gross margin $1.957M (40.5% of revenue), +33.4% YoY; operating income $448K (+140.9%).
- PBRT revenue up 82.4% to $2.358M; Gamma Knife same-center revenue down 12.5%.
- Cash $11.664M at Sep 30, 2022; unused credit line of $7M.
- Appointed Peter Gaccione as COO in September 2022.

## SEC filing metadata
- accession: 0001437749-22-026792
- form_type: 8-K
- ticker: AMS
- cik: 0000744825
- company_name: AMERICAN SHARED HOSPITAL SERVICES
- filed_at: 2022-11-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744825/000143774922026792/0001437749-22-026792-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744825/000143774922026792/asha20221109_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-026792
- JSON: https://secwatch.observer/filing/0001437749-22-026792.json
- Plain text: https://secwatch.observer/filing/0001437749-22-026792.txt

## Key facts
- Earnings Releases
  AMERICAN SHARED HOSPITAL SERVICES reported third quarter and nine months of fiscal 2022, ended September 30, 2022 results: revenue $4,828,000, net income $316,000, or $0.05 per diluted share, EPS $0.05 per diluted share.
  - Period: third quarter and nine months of fiscal 2022, ended September 30, 2022
  - Revenue: $4,828,000
  - Net income: $316,000, or $0.05 per diluted share
  - EPS: $0.05 per diluted share
  - Result: reported results
  source text: results for the third quarter and nine months of fiscal 2022, ended September 30, 2022. Third Quarter 2022 Financial Highlights ● Total revenue in the third quarter was $4,828,000, an increase of 17.8% from the comparable period in 2021. Total proton therapy revenue and fractions increased 82.4% and 40.1%, respectively, period-over-period. Gamma Knife
  evidence_url: https://www.sec.gov/Archives/edgar/data/744825/000143774922026792/0001437749-22-026792-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.